Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9

Biochemical and Biophysical Research Communications

Volumn 426, Issue 3, 2012, Pages 299-305

  Lee, Jae Woong ^a   Kim, Hyeng Soo ^a   Hwang, Junmo ^a   Kim, Young Hun ^a   Lim, Ga Young ^a   Sohn, Wern Joo ^a   Yoon, Suk Ran ^b   Kim, Jae Young ^a   Park, Tae Sung ^c   Oh, Seung Hwan ^d   Park, Kwon Moo ^e   Choi, Sang Un ^f   Ryoo, Zae Young ^a   Lee, Sanggyu ^a  

^a Kyungpook National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Inje University   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

C EBP ; DACH1; GATA 1; HOXA9; MEIS1; MLL AF9

Indexed keywords

BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CELL FATE DETERMINATION FACTOR DACH1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MIXED LINEAGE LEUKEMIA PROTEIN; MLL AF9 PROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; DNA BINDING; ENZYME SUBSTRATE COMPLEX; GENE OVEREXPRESSION; MICROARRAY ANALYSIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA; EYE PROTEINS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID; MICE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84866866454     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.048     Document Type: Article

References (21)

1. Mardon G., Solomon N.M., Rubin G.M. Dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 1994, 120:3473-3486.
2. Popov V.M., Zhou J., Shirley L.A., Quong J., Yeow W.S., Wright J.A., Wu K., Rui H., Vadlamudi R.K., Jiang J., Kumar R., Wang C., Pestell R.G. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res. 2009, 69:5752-5760.
3. Wu K., Jiao X., Li Z., Katiyar S., Casimiro M.C., Yang W., Zhang Q., Willmarth N.E., Chepelev I., Crosariol M., Wei Z., Hu J., Zhao K., Pestell R.G. Cell fate determination factor Dachshund reprograms breast cancer stem cell function. J. Biol. Chem. 2011, 286:2132-2142.
4. Lee J.W., Kim H.S., Kim S., Hwang J., Kim Y.H., Lim G.Y., Sohn W.J., Yoon S.R., Kim J.Y., Park T.S., Park K.M., Ryoo Z.Y., Lee S. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21(Cip1). Biochem. Biophys. Res. Commun. 2012.
5. Du J., Stankiewicz M.J., Liu Y., Xi Q., Schmitz J.E., Lekstrom-Himes J.A., Ackerman S.J. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J. Biol. Chem. 2002, 277:43481-43494.
6. Schuster M.B., Porse B.T. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell. Biofactors 2009, 35:227-231.
7. Frohling S., Dohner H. Disruption of C/EBPalpha function in acute myeloid leukemia. N. Engl. J. Med. 2004, 351:2370-2372.
8. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 2010, 11:585-593.
9. Lee S., Chen J., Zhou G., Shi R.Z., Bouffard G.G., Kocherginsky M., Ge X., Sun M., Jayathilaka N., Kim Y.C., Emmanuel N., Bohlander S.K., Minden M., Kline J., Ozer O., Larson R.A., LeBeau M.M., Green E.D., Trent J., Karrison T., Liu P.P., Wang S.M., Rowley J.D. Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proc. Natl. Acad. Sci. U S A 2006, 103:1030-1035.
10. Erfurth F.E., Popovic R., Grembecka J., Cierpicki T., Theisler C., Xia Z.B., Stuart T., Diaz M.O., Bushweller J.H., Zeleznik-Le N.J. MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. Proc. Natl. Acad. Sci. U S A 2008, 105:7517-7522.
11. Ueki N., Zhang L., Hayman M.J. Ski can negatively regulates macrophage differentiation through its interaction with PU.1. Oncogene 2008, 27:300-307.
12. Matsumoto A., Takeishi S., Kanie T., Susaki E., Onoyama I., Tateishi Y., Nakayama K., Nakayama K.I. P57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell. Stem Cell 2011, 9:262-271.
13. Forsberg E.C., Prohaska S.S., Katzman S., Heffner G.C., Stuart J.M., Weissman I.L. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 2005, 1:e28.
14. Zhou J., Liu Y., Zhang W., Popov V.M., Wang M., Pattabiraman N., Sune C., Cvekl A., Wu K., Jiang J., Wang C., Pestell R.G. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1. J. Biol. Chem. 2010, 285:40342-40350.
15. Hu Y.L., Passegue E., Fong S., Largman C., Lawrence H.J. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood 2007, 109:4732-4738.
16. Wong P., Iwasaki M., Somervaille T.C., So C.W., Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 2007, 21:2762-2774.
17. Schnabel C.A., Jacobs Y., Cleary M.L. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 2000, 19:608-616.
18. Wu K., Li A., Rao M., Liu M., Dailey V., Yang Y., Di Vizio D., Wang C., Lisanti M.P., Sauter G., Russell R.G., Cvekl A., Pestell R.G. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol. Cell Biol. 2006, 26:7116-7129.
19. Wu K., Katiyar S., Witkiewicz A., Li A., McCue P., Song L.N., Tian L., Jin M., Pestell R.G. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res. 2009, 69:3347-3355.
20. Nan F., Lu Q., Zhou J., Cheng L., Popov V.M., Wei S., Kong B., Pestell R.G., Lisanti M.P., Jiang J., Wang C. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol. Ther. 2009, 8:1534-1539.
21. Gilbert P.M., Mouw J.K., Unger M.A., Lakins J.N., Gbegnon M.K., Clemmer V.B., Benezra M., Licht J.D., Boudreau N.J., Tsai K.K., Welm A.L., Feldman M.D., Weber B.L., Weaver V.M. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J. Clin. Invest. 2010, 120:1535-1550.